Mark C. Schiller serves as Executive at Kezar Life Sciences, Inc., where they oversee executive responsibilities. Since joining the company, Mark C. Schiller has executed 1 insider transactions totaling $3.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 2, 2024 involved selling 6,688 shares valued at $3.9K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 2, 2024 | KZR | $3.9K | Sale | 6,688 | $0.58 | Discretionary |
Mark C. Schiller currently holds 33,007 shares of Kezar Life Sciences, Inc. (KZR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark C. Schiller has been a net seller of KZR stock. They have purchased $0 and sold $3.9K worth of shares.
Mark C. Schiller's most recent insider trade was on Jul 2, 2024, when they sold 6,688 shares at $0.58 per share.
Get notified when new Form 4 filings are submitted